A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma

Qureshi, S; Khandelwal, R; Madhavi, M; Khurana, N; Gupta, N; Choudhary, SK; Suresh, RA; Hazarika, L; Srija, CD; Sharma, K; Hindala, MR; Hussain, T; Nayarisseri, A; Singh, SK

Nayarisseri, A (corresponding author), Eminent Biosci, In Silico Res Lab, Indore 452010, Madhya Pradesh, India.; Nayarisseri, A; Singh, SK (corresponding author), Alagappa Univ, Dept Bioinformat, Comp Aided Drug Designing & Mol Modeling Lab, Karaikkudi 630003, Tamil Nadu, India.

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021; 21 (9): 790

Abstract

Background: Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma characterized by the mutation and overexpression of the cyclin D1 protein by ......

Full Text Link